Literature DB >> 16059480

Much ado about something or nothing: behavioral problems with levetiracetam use in epilepsy patients.

Patricia E Penovich.   

Abstract

Entities:  

Year:  2004        PMID： 16059480      PMCID： PMC1176352          DOI： 10.1111/j.1535-7597.2004.44009.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.

Authors:  S D Shorvon; A Löwenthal; D Janz; E Bielen; P Loiseau
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

2.  Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.

Authors:  J J Cereghino; V Biton; B Abou-Khalil; F Dreifuss; L J Gauer; I Leppik
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

3.  Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.

Authors:  E Ben-Menachem; U Falter
Journal:  Epilepsia       Date:  2000-10       Impact factor: 5.864

Review 4.  Safety profile of levetiracetam.

Authors:  C Harden
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

5.  A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

Authors:  T Betts; T Waegemans; P Crawford
Journal:  Seizure       Date:  2000-03       Impact factor: 3.184

6.  Levetiracetam psychosis in children with epilepsy.

Authors:  E H Kossoff; G K Bergey; J M Freeman; E P Vining
Journal:  Epilepsia       Date:  2001-12       Impact factor: 5.864

7.  Levetiracetam in refractory pediatric epilepsy.

Authors:  James W Wheless; Yu-tze Ng
Journal:  J Child Neurol       Date:  2002-06       Impact factor: 1.987

8.  Discontinuation of levetiracetam because of behavioral side effects: a case-control study.

Authors:  J R White; T S Walczak; I E Leppik; J Rarick; T Tran; T E Beniak; D J Matchinsky; R J Gumnit
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910
  8 in total
  2 in total

Review 1.  Levetiracetam add-on for drug-resistant focal epilepsy.

Authors:  Gashirai K Mbizvo; Bharath Chandrasekar; Sarah J Nevitt; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-06-30

Review 2.  Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Authors:  Gashirai K Mbizvo; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.